Withdrawal Of Market Authorization For Prexige (lumiracoxib) - For Health Professionals

Prexige (lumiracoxib) Recall Summary Prexige, a pain and inflammation medication, has had its market authorization withdrawn in Canada. The withdrawal was due to safety concerns identified after the drug was already being used by patients. This affects all Canadian patients who were taking or prescribed this medication.

Category

drug recall

Country

Canada

Agency

HC-DRUGS

Recall date

2007-10-05

Status

Closed

Distribution

Canada-wide

Official recall notice from HC-DRUGS

Recall details on Nibble Recalls: https://trynibble.app/recalls/a38f939a-e611-47c2-a487-dfefbb992644